USA TODAY
To prove their COVID-19 vaccines worked, companies had to enroll more than 100,000 participants in monthslong clinical trials. Next time, Peter Gilbert wants such tests to require only a few hundred people and eight weeks time.
To get there, Gilbert and others have to figure out how much protection people need to avoid hospitalization and death from COVID-19, or even to prevent getting infected at all.
But 15 months after COVID-19 shut down most of the world, it s still not clear what level of immune protection is enough. I haven t seen people tossing around a number, and I m a little surprised by that. I would have thought we were further along by now, said John Grabenstein, editor for the Immunization Action Coalition and former senior scientist and director for the U.S. Department of Defense military immunization program.
. (Tribune News Service) To prove their COVID-19 vaccines worked, companies had to enroll more than 100,000 participants in monthslong clinical trials. Next time, Peter Gilbert wants such tests to require only a few hundred people and eight weeks time. To get there, Gilbert and others have to figure out how much protection people need to avoid hospitalization and death from COVID-19, or even to prevent getting infected at all. But 15 months after COVID-19 shut down most of the world, it s still not clear what level of immune protection is enough. I haven t seen people tossing around a number, and I m a little surprised by that. I would have thought we were further along by now, said John Grabenstein, editor for the Immunization Action Coalition and former senior scientist and director for the U.S. Department of Defense military immunization program.
What level of antibodies protect against COVID-19? Researchers are rushing to find out Elizabeth Weise, USA TODAY
Replay Video UP NEXT
To prove their COVID-19 vaccines worked, companies had to enroll more than 100,000 participants in monthslong clinical trials. Next time, Peter Gilbert wants such tests to require only a few hundred people and eight weeks time.
To get there, Gilbert and others have to figure out how much protection people need to avoid hospitalization and death from COVID-19, or even to prevent getting infected at all.
But 15 months after COVID-19 shut down most of the world, it s still not clear what level of immune protection is enough.
Biden Caves to Fringe Progressivism at Our Expense
A few weeks ago, a positively daft idea emerged from the progressive left’s vast repository of daft ideas.
In a video message, the self-described socialist Sen. Bernie Sanders joined with progressive House members and called on the Biden administration to waive the intellectual property rights that helped produce a series of near-miraculous COVID-19 vaccines. The senator concluded with a rousing non-sequitur: “We need a people’s vaccine, not a profit vaccine.”
It was a terrible idea, and most recognized it as such at the time.
Animated by a crippling fear of emerging variants in the developing world and armed with an irrational mistrust of any innovation that contributes to the public good that also generates revenue for its innovators, progressives convinced themselves that the firms delivering us from the pandemic must be punished.
CVS, Walgreens are biggest sources of vaccine waste, survey finds Big pharmacy chains say they are addressing early problems Follow Us
Question of the Day
In this March 17, 2020, file photo, Pharmacist Evelyn Kim, wears a mask and gloves at the CVS pharmacy at Target in the Tenleytown area of Washington. The Biden administration will begin providing COVID-19 vaccines to U.S. pharmacies, including CVS, . more > By Shen Wu Tan - The Washington Times - Tuesday, May 4, 2021
CVS and Walgreens, two of the nation’s biggest pharmacy chains, have tossed out the bulk of their unused COVID-19 vaccine doses and wasted more doses than most states combined, according to a new report.